AU1851797A - Cyclic peptide antifungal agents - Google Patents

Cyclic peptide antifungal agents

Info

Publication number
AU1851797A
AU1851797A AU18517/97A AU1851797A AU1851797A AU 1851797 A AU1851797 A AU 1851797A AU 18517/97 A AU18517/97 A AU 18517/97A AU 1851797 A AU1851797 A AU 1851797A AU 1851797 A AU1851797 A AU 1851797A
Authority
AU
Australia
Prior art keywords
antifungal agents
cyclic peptide
peptide antifungal
cyclic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18517/97A
Inventor
Stacy K. Henle
William W. Turner Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603151.3A external-priority patent/GB9603151D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1851797A publication Critical patent/AU1851797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU18517/97A 1996-02-01 1997-01-29 Cyclic peptide antifungal agents Abandoned AU1851797A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1094696P 1996-02-01 1996-02-01
US010946 1996-02-01
GBGB9603151.3A GB9603151D0 (en) 1996-02-15 1996-02-15 Cyclic peptide antifungal agents
GB9603151 1996-02-15
PCT/US1997/001607 WO1997027864A1 (en) 1996-02-01 1997-01-29 Cyclic peptide antifungal agents

Publications (1)

Publication Number Publication Date
AU1851797A true AU1851797A (en) 1997-08-22

Family

ID=26308710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18517/97A Abandoned AU1851797A (en) 1996-02-01 1997-01-29 Cyclic peptide antifungal agents

Country Status (5)

Country Link
EP (1) EP0881907A4 (en)
JP (1) JP2001503015A (en)
AU (1) AU1851797A (en)
CA (1) CA2244238A1 (en)
WO (1) WO1997027864A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
WO2000011023A2 (en) 1998-08-20 2000-03-02 Eli Lilly And Company Ring modified cyclic peptide analogs
ES2272096T3 (en) 1998-12-09 2007-04-16 Eli Lilly And Company PURIFICATION OF CYCLOPEPTIDIC COMPOUNDS OF EQUINOCANDINA.
JP4272359B2 (en) 1999-03-03 2009-06-03 イーライ リリー アンド カンパニー Echinocandin / Carbohydrate Complex
ATE338060T1 (en) 1999-03-03 2006-09-15 Lilly Co Eli FORMATION AND ANION EXCHANGE OF INNER CRYSTALLINE AMMONIUM SALTS OF ECHINOCANDIN B
IL145185A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin pharmaceutical formulations containing micelle-forming surfactants
AU771727B2 (en) 1999-03-03 2004-04-01 Eli Lilly And Company Processes for making pharmaceutical oral ECB formulations and compositions
WO2004035563A1 (en) * 2002-10-17 2004-04-29 Syngenta Participations Ag 3-heterocyclylpyridine derivatives useful as herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
TW264477B (en) * 1992-03-19 1995-12-01 Lilly Co Eli
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound

Also Published As

Publication number Publication date
CA2244238A1 (en) 1997-08-07
EP0881907A4 (en) 2000-05-10
JP2001503015A (en) 2001-03-06
EP0881907A1 (en) 1998-12-09
WO1997027864A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
AU8687798A (en) Cyclic peptide antifungal agents
AU5799196A (en) Cyclic peptide antifungal agents
AU5383496A (en) Cyclic peptide antifungal agents
AU4325897A (en) Antifungal agents
GB9525474D0 (en) Antifungal proteins
AU5799096A (en) Cyclic peptide antifungal agents
AU2686099A (en) Cyclic peptide antifungal agents
AU4059197A (en) Amino-lipopeptide antifungal agents
AU4281999A (en) Peptide
AU2131195A (en) Prophenins - antibiotic peptides
GB9718110D0 (en) Peptides
AU1851797A (en) Cyclic peptide antifungal agents
AU1725299A (en) Antifungal and antibacterial peptides
AU1999999A (en) Contryphan peptides
GB9700154D0 (en) Peptides
AUPM489194A0 (en) Peptides
EP0996457A4 (en) Fsh-releasing peptides
GB9603151D0 (en) Cyclic peptide antifungal agents
AU6408499A (en) Cyclic peptides as antifungal agents
GB9613705D0 (en) Novel peptides
AU2268700A (en) Socs-box containing peptides
GB9606552D0 (en) Antifungal proteins
GB9626362D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9605904D0 (en) Peptides